Publicaciones

Todas
Glyco-checkpoints e inmunosupresión tumoral
Glyco-checkpoints en fenómenos de vascularización
Cáncer colorrectal (CCR)
Adenocarcinoma ductal de páncreas (PDAC)
Cáncer de mama
Glioblastoma
Cáncer de hígado
Cáncer renal
Cáncer de pulmón
Cáncer de piel
Autoinmunidad e inflamación
Autoinmunidad e inflamaciónGlyco-checkpoints e inmunosupresión tumoralGlyco-checkpoints en fenómenos de vascularizaciónTodas

Glycan-Binding Proteins in Immunity

Rabinovich GA, et al - Annu Rev Immunol. 2026 Apr
Glyco-checkpoints e inmunosupresión tumoral

A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1...

Li R, et al - Sci Transl Med. 2024 Oct
Glyco-checkpoints e inmunosupresión tumoral

Targeting galectin-driven regulatory circuits in cancer and fibrosis

Mariño KV, et al - Nat Rev Drug Discov. 2023 Apr

Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs

Pinto NA, et al - Cell Death Differ. 2023 Apr

Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune...

Segovia M, et al - Cancer Cell. 2019 May
Glyco-checkpoints e inmunosupresión tumoral

IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial...

Song M, et al - Nature. 2018 Oct

Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease

Dalotto-Moreno T, et al - Cancer Res. 2013
Glyco-checkpoints e inmunosupresión tumoral

A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1...

Laderach DJ, etc al - Cancer Res. 2013 Jan

Targeted inhibition of galectin-1 gene expression in tumor cells results in...

Rubinstein N, et al - Cancer Cell. 2004 Mar